EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Drug delivery for neurodegenerative diseases is a problem, but lipid nanocarriers could provide the answer

Md Rajdoula Rafe

Nanotheranostics · 2024

DOI: 10.7150/ntno.88849 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nanotheranostics, 2024. Verfasst von Md Rajdoula Rafe. Beteiligte Einrichtung: Department of Neuroscience, City University of Hong Kong, Kowloon, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Neurodegenerative Diseases. Die Arbeit wurde bisher 15-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative disorders encompass diseases that involve the degeneration of neurons, particularly those within the central nervous system. These are the most commonly observed disorders among the geriatric population. The treatment or management of this condition presents additional challenges due to therapeutics that may not be as effective as desired. The primary obstacle that often hinders the efficacy of therapy is the existence of a blood-brain barrier (BBB). The BBB serves as a vital safeguard for the brain, effectively obstructing the passage of drugs into the brain cells. Hence, the management of damaging neurodegenerative conditions such as Alzheimer's disease (AD), Parkinson's disease (PD), Cerebrovascular diseases (CVDs), Huntington's disease (HD), and Multiple sclerosis (MS) is currently the primary area of research interest. The innovative utilization of nanoparticles as drug carriers provides renewed optimism in addressing many complicated medical conditions. In this article, I have aimed to gather published information regarding various lipid nanoparticles that can efficiently transport medication to the brain to address neurodegenerative disorders. According to the published literature, liposomes, solid-lipid nanoparticles, nanostructured nanoparticles, microemulsions, and nanoemulsions are potential nanocarriers that can treat neurodegenerative disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesAgedHumansDrug Delivery SystemsBrainBlood-Brain BarrierLipids

Stichwörter der Autor:innen

blood-brain barriercentral nervous system (CNS)nanocarriersnanoparticlesneurodegenerative disorders

Substanzen

Lipids

Autor:innen und Institutionen

  • Department of Neuroscience, City University of Hong Kong, Kowloon, Hong Kong SAR, China.
  • Department of Pharmacy, Jagannath University, Dhaka-1100, Bangladesh.

Zitieren

APA

Rafe, M. R. (2024). Drug delivery for neurodegenerative diseases is a problem, but lipid nanocarriers could provide the answer. Nanotheranostics. https://doi.org/10.7150/ntno.88849

Vancouver

Rafe MR. Drug delivery for neurodegenerative diseases is a problem, but lipid nanocarriers could provide the answer. Nanotheranostics. 2024. doi:10.7150/ntno.88849

BibTeX
@article{Rafe2024,
  author = {Rafe, Md Rajdoula},
  title = {Drug delivery for neurodegenerative diseases is a problem, but lipid nanocarriers could provide the answer},
  journal = {Nanotheranostics},
  year = {2024},
  doi = {10.7150/ntno.88849}
}
Kostenlos starten →